Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,912 | 4 | 46.5% |
| Honoraria | $9,240 | 4 | 39.4% |
| Travel and Lodging | $3,045 | 8 | 13.0% |
| Food and Beverage | $258.61 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | $23,339 | 21 | $0 (2024) |
| Novo Nordisk Inc | $101.71 | 1 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $15.14 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,489 | 4 | Rhythm Pharmaceuticals, Inc. ($2,387) |
| 2023 | $8,689 | 8 | Rhythm Pharmaceuticals, Inc. ($8,689) |
| 2022 | $12,262 | 10 | Rhythm Pharmaceuticals, Inc. ($12,262) |
| 2019 | $15.14 | 1 | Ultragenyx Pharmaceutical Inc. ($15.14) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $101.71 | General |
| 10/29/2024 | Rhythm Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $729.00 | General |
| 07/27/2024 | Rhythm Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $675.00 | General |
| 01/07/2024 | Rhythm Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $983.26 | General |
| 11/02/2023 | Rhythm Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $2,700.00 | General |
| 11/02/2023 | Rhythm Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $230.46 | General |
| 11/02/2023 | Rhythm Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $69.59 | General |
| 11/02/2023 | Rhythm Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.00 | General |
| 11/01/2023 | Rhythm Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 10/15/2023 | Rhythm Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $1,125.00 | General |
| 08/01/2023 | Rhythm Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,533.08 | General |
| 05/18/2023 | Rhythm Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $900.00 | General |
| 12/13/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Consulting Fee | Cash or cash equivalent | $6,525.00 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Travel and Lodging | Cash or cash equivalent | $606.30 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Travel and Lodging | Cash or cash equivalent | $457.20 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | Cash or cash equivalent | $74.56 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Travel and Lodging | Cash or cash equivalent | $19.96 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | Cash or cash equivalent | $8.10 | General |
| Category: Genetic Disease | ||||||
| 11/21/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Travel and Lodging | Cash or cash equivalent | $3.25 | General |
| Category: Genetic Disease | ||||||
| 11/09/2022 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Honoraria | Cash or cash equivalent | $4,515.00 | General |
| Category: Genetic Disease | ||||||
| 11/02/2022 | Rhythm Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.23 | General |
| 05/06/2019 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: XLH | ||||||
About Dr. Christian Roth, MD
Dr. Christian Roth, MD is a Pediatrics healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073606174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christian Roth, MD has received a total of $23,456 in payments from pharmaceutical and medical device companies, with $2,489 received in 2024. These payments were reported across 23 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($10,912).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Endocrinology
- Location Seattle, WA
- Active Since 10/02/2006
- Last Updated 02/03/2009
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1073606174
Products in Payments
- Imcivree (Drug) $12,232
- CRYSVITA (Drug) $15.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Seattle
Allison Wheeler, M.d, M.D
Pediatrics — Payments: $251,627
Dr. Brian Morray, M.d, M.D
Pediatrics — Payments: $172,893
Petter Bjornstad, Md, MD
Pediatrics — Payments: $140,626
Lauren Huang, Ppcnp-Bc, PPCNP-BC
Pediatrics — Payments: $103,048
Dr. Susan Shenoi, M.d, M.D
Pediatrics — Payments: $50,061
Troy Torgerson
Pediatrics — Payments: $39,248